ZA876738B - Polypeptide related compounds,compositions and test kits useful for the alleviation,treatment and diagnosis of autoimmune diseases - Google Patents

Polypeptide related compounds,compositions and test kits useful for the alleviation,treatment and diagnosis of autoimmune diseases

Info

Publication number
ZA876738B
ZA876738B ZA876738A ZA876738A ZA876738B ZA 876738 B ZA876738 B ZA 876738B ZA 876738 A ZA876738 A ZA 876738A ZA 876738 A ZA876738 A ZA 876738A ZA 876738 B ZA876738 B ZA 876738B
Authority
ZA
South Africa
Prior art keywords
alleviation
diagnosis
compositions
treatment
autoimmune diseases
Prior art date
Application number
ZA876738A
Inventor
Van Eden Willem
Egbertus Rudolfus Thole Jelle
Dirk Anthonie Van Embden Johannes
Van Der Zee Ruurd
Robert Cohen Irun
Original Assignee
De Staat De Nederlanded Vertegenwoordigd Door De Minister Van Welzijn, Volksgezondheid En Cultuur
Rijksuniversiteit Te Utrecht
Yeda Research And Development Co. Ltd.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by De Staat De Nederlanded Vertegenwoordigd Door De Minister Van Welzijn, Volksgezondheid En Cultuur, Rijksuniversiteit Te Utrecht, Yeda Research And Development Co. Ltd. filed Critical De Staat De Nederlanded Vertegenwoordigd Door De Minister Van Welzijn, Volksgezondheid En Cultuur
Publication of ZA876738B publication Critical patent/ZA876738B/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/86—Viral vectors
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/35—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Mycobacteriaceae (F)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/74—Vectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/564—Immunoassay; Biospecific binding assay; Materials therefor for pre-existing immune complex or autoimmune disease, i.e. systemic lupus erythematosus, rheumatoid arthritis, multiple sclerosis, rheumatoid factors or complement components C1-C9
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/24011—Poxviridae
    • C12N2710/24111—Orthopoxvirus, e.g. vaccinia virus, variola
    • C12N2710/24141—Use of virus, viral particle or viral elements as a vector
    • C12N2710/24143—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Physics & Mathematics (AREA)
  • Biophysics (AREA)
  • Microbiology (AREA)
  • Hematology (AREA)
  • Plant Pathology (AREA)
  • Urology & Nephrology (AREA)
  • Medicinal Chemistry (AREA)
  • Food Science & Technology (AREA)
  • Pathology (AREA)
  • Analytical Chemistry (AREA)
  • Rheumatology (AREA)
  • General Physics & Mathematics (AREA)
  • Cell Biology (AREA)
  • Rehabilitation Therapy (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Virology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
ZA876738A 1986-09-09 1987-09-09 Polypeptide related compounds,compositions and test kits useful for the alleviation,treatment and diagnosis of autoimmune diseases ZA876738B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
NL8602270A NL8602270A (en) 1986-09-09 1986-09-09 Use of Mycobacterium bovis BCG polypeptide - for alleviation, treatment and diagnosis of auto-immune diseases, esp. arthritic conditions

Publications (1)

Publication Number Publication Date
ZA876738B true ZA876738B (en) 1988-03-14

Family

ID=19848516

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA876738A ZA876738B (en) 1986-09-09 1987-09-09 Polypeptide related compounds,compositions and test kits useful for the alleviation,treatment and diagnosis of autoimmune diseases

Country Status (2)

Country Link
NL (1) NL8602270A (en)
ZA (1) ZA876738B (en)

Also Published As

Publication number Publication date
NL8602270A (en) 1988-04-05

Similar Documents

Publication Publication Date Title
LV10654B (en) Method for preparation of diagnostic composition and the use thereof
AU4297685A (en) Compositions for the allevation, treatment and diagnosis of arthritic disease and related conditions
EP0205579A4 (en) Methods and compositions useful in the diagnosis and treatment of autoimmune diseases.
IL83817A0 (en) Polypeptide useful for the alleviation,treatment and diagnosis of autoimmune diseases,especially arthritic conditions,compounds related to said peptide,micro-organisms expressing said peptide or a compound related to said peptide,as well as diagnostic compositions and test kits
EP0493362A3 (en) Compositions and kits for the treatment of oral diseases
GB2188844B (en) Pharmaceutical composition for the treatment of psoriasis
NO874530L (en) PROCEDURE FOR THE PREPARATION OF NOR-STATIN OR NOR-CYCLOSTATIN POLYPEPTIDES.
EP0243002A3 (en) Pharmaceutical composition for the treatment of periodontal diseases
AU551900B2 (en) Anthralin compositions for treatment of skin diseases
FR2651435B1 (en)
IL82840A0 (en) Method and compositions for the determination of occult blood
BG49522A1 (en) Pharmaceutist composition accelarating the healing of mounds
GB8724204D0 (en) Determining composition of solid body
AU7357687A (en) Diagnostic kit for sexually transmitted diseases
ZA876738B (en) Polypeptide related compounds,compositions and test kits useful for the alleviation,treatment and diagnosis of autoimmune diseases
PT84784A (en) Process for the preparation of benzoxazolyl- and benzothiazolylanilines and of fungicidal compositions containing the same
TR24449A (en) USE AS THE PROCEDURE V AND FUNGUSID FOR THE PREPARATION OF TIYAZINOL TUEREVLER
PT79853B (en) Process for the preparation of an highly solubilized protein
HUT45622A (en) Process for making medical compositions for diagnosing tumours
GB2197871B (en) Protein derived from the basal cells of the epidermis
IL82191A0 (en) Polypeptides,processes for the preparation thereof and diagnostic kits containing the same
GB2185477B (en) Novel bicyclic lactam, pharmacologically active compositions thereof, processes for the preparation thereof and their medical use
AU7692987A (en) Reagent kit, its use and diagnostic process for the detection of hpasp(human pancreatic specific protein)
GB2268062B (en) Use of gamma amino butyric acid autoreceptor antagonists for the treatment of pain
GB8621182D0 (en) Diagnostic kit